Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
04/2002
04/17/2002EP1196380A2 Indoles and indazoles for the treatment of migraine
04/17/2002EP0968212B1 Method of making (1s, 4r)-1-azabicyclo 2.2.1]heptan-3-one and (1r, 4s), 1-azabicyclo 2.2.1]heptan-3-one
04/17/2002CN1345332A C-terminal modified (N-substituted)-2 indolylcarbonyldiptides as inhibitors of ICE/CED-3 family of cysteine proteases
04/17/2002CN1345314A Amine derivatives as protease inhibitors
04/17/2002CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors
04/17/2002CN1345304A Substituted aniline compounds
04/17/2002CN1345303A Oxamic acids and derivatives as thyroid receptor ligands
04/17/2002CN1345238A Method for treatment of neurological or neuropsychiatric disorders
04/17/2002CN1082959C Substituted benzothienylpiperazines, their use as medicaments and processes for their preparation
04/17/2002CN1082945C Alkoxiyimino acetamide
04/16/2002USRE37664 Use of derivatives of N-phenl-3,4,5,6-tetrahydrophthalimide for the desiccation and abscission of plant organs
04/16/2002US6372919 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
04/16/2002US6372779 Anthracene derivatives with carbamoyl groups, amido groups, urea groups and sulfonamide groups
04/16/2002US6372778 Sulfonamide inhibitors of aspartyl protease
04/16/2002US6372762 Heterocyclic compounds for nervous system disorders
04/16/2002US6372759 Antithrombotic agents
04/16/2002US6372752 Enzyme inhibitors, respiratory system disorders, tuberculosis and mycobacterium bactericides
04/16/2002CA2088980C Pro-drugs for cck antagonists
04/16/2002CA2076948C Isatineoxime derivatives, their preparation and use
04/11/2002WO2002028839A1 Benzimidazole and indole derivatives as crf receptor modulators
04/11/2002WO2002028832A2 Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers
04/11/2002WO2002028831A1 Inhibitors of prenyl-protein transferase
04/11/2002WO2002028830A1 Novel phenylalanine derivatives
04/11/2002WO2002028820A1 Nitroso diphenylamine derivatives
04/11/2002WO2002028347A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
04/11/2002WO2001090069B1 Novel calcium receptor active molecules and method for preparing same
04/11/2002WO2001083450A3 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
04/11/2002WO2000075237A3 pH SENSITIVE CYANINE DYES AS REACTIVE FLUORESCENT REAGENTS
04/11/2002US20020042517 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
04/11/2002US20020042441 N-substituted indoles useful in the treatment of diabetes
04/11/2002US20020042399 Analgesics; skin disorders
04/11/2002CA2425281A1 Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers
04/11/2002CA2425185A1 Benzimidazole and indole derivatives as crf receptor modulators
04/11/2002CA2424684A1 Nitroso diphenylamine derivatives
04/11/2002CA2424222A1 Inhibitors of prenyl-protein transferase
04/10/2002EP1195371A1 Process for the preparation of tricyclic amino alcohol derivatives
04/10/2002EP1194375A1 Synthetic porous crystalline mcm-68, its synthesis and use
04/10/2002EP1194227A1 Preparation and use of ionic liquids in microwave-assisted chemical transformations
04/10/2002EP1194135A2 Methods of treating fungal infections with inhibitors of nad synthetase enzyme
04/10/2002EP0912567B1 Carboline derivatives
04/10/2002EP0741132B1 Indole derivatives
04/10/2002EP0739351B1 Monomeric diols and phosphate linked oligomers formed therefrom
04/10/2002CN1344256A (Hetero) aryl-bicyclic heteroaryl derivatives, their prepn. and their use as protease inhibitors
04/10/2002CN1344244A Synthesis method of nitroxymethylphenyl esters of aspirin derivatives
04/10/2002CN1343662A Preparing method of 4-substrated-1H-indole-3-glyoxyly amine
04/10/2002CN1082509C Camptothecin-skeleton compounds isolated from mappia foetida and use thereof as syntones for medicaments as well as therapeutical agents
04/09/2002US6369238 Processes for the preparation of derivatives of 4a, 5, 9, 10, 11, 12-hexahydro-6H-benzofuro-[3a, 3, 2-ef][2]benzazepine
04/09/2002US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors
04/09/2002US6369076 Analgesics
04/09/2002US6369069 Cardiovascular disorders
04/09/2002US6369059 Tetracyclic derivatives, process of preparation and use
04/09/2002US6368850 Preparing 1-amino-4-(hydroxymethyl)-2-cyclopentene and n-acetylamino-alcohol hydrolase activity obtainable from these microorganisms.
04/04/2002WO2002026891A1 Modified carbocyanine dyes and their conjugates
04/04/2002WO2002026720A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa
04/04/2002WO2002026707A1 Novel compounds
04/04/2002WO2002026697A2 Aromatic derivatives with hiv integrase inhibitory properties
04/04/2002WO2002026696A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
04/04/2002WO2002026683A1 Tandem acyl-claisen rearrangement in the preparation of chiral products
04/04/2002WO2001090717A3 Linker arms for nanocrystals and compounds thereof
04/04/2002WO2001090716A3 Linker arms for nanocrystals and compounds thereof
04/04/2002WO2001085694A3 Substituted diamide derivatives useful as motilin antagonists
04/04/2002WO2001079169A3 Prostaglandin d2 receptor antagonists
04/04/2002WO2001074815A3 Phenyl-substituted imidazopyridines
04/04/2002WO2001074810A3 Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
04/04/2002WO2001074773A3 Phenyl-substituted indoles as histamine h3-receptor antagonists
04/04/2002WO2001058870A3 Solid-phase process for making indole compounds
04/04/2002US20020040003 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus
04/04/2002US20020040002 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
04/03/2002EP1192945A2 Use of an estrogen agonist/antagonist for treating osteoarthritis
04/03/2002EP1192191A1 Method for producing condensation compounds
04/03/2002EP1192135A2 Serine protease inhibitors
04/03/2002EP1192132A2 Serine protease inhibitors
04/03/2002EP1192131A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
04/03/2002EP1192129A2 Pharmaceutical compounds
04/03/2002EP1192126A1 C-2 hydroxyl protected-n-acyl(2r,3s)-3-phenylisoserine activated esters and methods for production thereof
04/03/2002EP1053472A4 Energy transfer dyes
04/03/2002CN1343208A Pyridopyranoazepine derivatives, preparation and therapeutic use
04/03/2002CN1342457A Method for preventing vomit and sexual disorder using tetrahydrobenzo [cd] indole-6-formylamine compound
04/02/2002US6365754 Process for producing erythro-3-amino-2-hydroxybutyric acid derivatives
04/02/2002US6365753 Excellent preferential effects on weeds; grasses; nonphytotoxic to crops e.g. wheat; barley; corn
04/02/2002US6365617 Indole and indazole urea-peptoids as thrombin receptor antagonists
04/02/2002US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/02/2002US6365564 Asymmetrical imide bleach activators and compositions employing the same
04/02/2002US6365195 Fungicidal active compound combinations
04/02/2002CA2059610C 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments
04/02/2002CA2056066C A physical form of n-[4-[5-(cyclopentyloxycarbony)amino-1-methylindol-3yl-methy1]-3-methoxybenzoy1]-2-methlbenzenesulphonamide, processes for its preparation and compositions containing it
03/2002
03/28/2002WO2002024815A1 Cyanine dyes
03/28/2002WO2002024672A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
03/28/2002WO2002024653A1 Compounds and methods for modulation of estrogen receptors
03/28/2002WO2002024648A2 Process for the preparation of cell proliferation inhibitors
03/28/2002WO2002024636A2 N-acylsulfonamide apoptosis promoters
03/28/2002WO2002024635A2 Aminoalcohol derivatives
03/28/2002WO2002024632A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
03/28/2002WO2002024631A1 Process to prepare (2s)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1h-indene-5-carboxamide
03/28/2002WO2002024613A2 Resorcinol derivatives
03/28/2002WO2002024194A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
03/28/2002WO2001097751A3 New formulation comprising a betablocker and optionally a cholesterol-lowering agent
03/28/2002WO2001096336A3 6,5-fused bicyclic heterocycles
03/28/2002WO2001077075A3 Inhibitors of inflammation and reperfusion injury
03/28/2002WO2001064676A3 INHIBITORS OF p38-α KINASE